This is the PrivCo Investor Profile for Abingworth Management Ltd.
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor Abingworth Management Ltd.
To unlock all information in this profile: Upgrade to PrivCo Premium

Abingworth Management Ltd.

What's included with your PrivCo Premium Subscription:
Next Actions on Abingworth Management Ltd.:
View Deal ActivityView Direct E-mail Contacts

Investor Summary

Abingworth Management Ltd. is a London, United Kingdom-based venture capital firm. Founded in 1973, Abingworth Management Ltd. considers seed and early stage investments as well as PIPE transactions.

Investor Overview

Basic Information

Investor Type:Venture Capital
Year Founded:1973
Address:38 Jermyn Street
City:London
Country:United Kingdom
Phone:View
Fax:View
Website:www.abingworth.com

Investment Preferences

Preferred Stage:Seed
Early Stage
PIPE
Mid Stage / Expansion

Investor Contacts

Below are direct e-mail contacts for senior professionals at Abingworth Management Ltd..
Full contact details are available with a PrivCo Premium Subscription.
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
NameTitle
Ken HaasVenture Partner
Vincent MilesVenture Partner
Andy SandhamVenture Partner
David LeathersSpecial Partner
John ShieldsPrincipal, Science and Technology
Andrew SinclairPortfolio Manager
James AbellPartner and CFO
Michael F. BighamPartner
Joe AndersonPartner
Tim HainesPartner
Genghis Lloyd-HarrisPartner
Jonathan MacQuittyPartner
David MayerPartner
Stephen BuntingManaging Partner

Private Deal History

This table is intended to portray Abingworth Management Ltd. PrivCo-covered market activity. Click below for Deal Details and Private Company Reports.
All data before 2006 is completely free to view! To access data from 2006 onward:
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateTargetTarget IndustryDeal TypeTotal Deal AmountStatus
May. 2013ViewBiopharmaceuticalsFundingViewCompletedDetails
Mar. 2013ViewOptical/Ophthalmic Products Distribution ServicesFundingViewCompletedDetails
Feb. 2013ViewMedical Device Design & ManufacturingFundingViewCompletedDetails
Jan. 2013ViewMedical Devices & EquipmentFundingViewCompletedDetails
Jul. 2012ViewBiopharmaceuticals
Pharmaceuticals		FundingViewCompletedDetails
May. 2012ViewMedical Device & Equipment ManufacturingFundingViewCompletedDetails
Mar. 2012ViewMedical Device & Equipment Manufacturing
Prosthetics		FundingViewCompletedDetails
Feb. 2012ViewMedical Device Design & ManufacturingFundingViewCompletedDetails
Jan. 2012ViewDrug Delivery TechnologyAcquisitionViewCompletedDetails
Jan. 2012ViewBiotechnologyFundingViewCompletedDetails
Sep. 2011ViewDrug Delivery TechnologyFundingViewCompletedDetails
May. 2011ViewHealth & Medical SoftwareFundingViewCompletedDetails
Oct. 2010ViewMedical Diagnostic EquipmentFundingViewCompletedDetails
Oct. 2010ViewBiotechnologyFundingViewCompletedDetails
Oct. 2010ViewMedical Device Design & ManufacturingFundingViewCompletedDetails
Aug. 2010ViewBiopharmaceuticals
Biotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Jul. 2010ViewDrug Delivery TechnologyFundingViewCompletedDetails
May. 2010ViewMedical Device Design & ManufacturingFundingViewCompletedDetails
Dec. 2009ViewBiotechnologyFundingViewCompletedDetails
Sep. 2009ViewBiochemicals
Pharmaceuticals		FundingViewCompletedDetails
Sep. 2009ViewBiotechnology
Medical Diagnostic Equipment		FundingViewCompletedDetails
Jun. 2009ViewBiotechnologyFundingViewCompletedDetails
Mar. 2009ViewClinical Research Services
Pharmaceutical Research & Drug Discovery		FundingViewCompletedDetails
Feb. 2009ViewElectrical Equipment & Appliances ManufacturingAcquisitionViewCompletedDetails
Sep. 2008ViewDrug Delivery TechnologyFundingViewCompletedDetails
Sep. 2008ViewMedical Diagnostic EquipmentFundingViewCompletedDetails
Jul. 2008ViewBiotherapeuticsFundingViewCompletedDetails
Jan. 2008ViewBiochemicals
Pharmaceuticals		FundingViewCompletedDetails
Jan. 2008ViewBiotechnology
Medical Diagnostic Equipment		FundingViewCompletedDetails
Dec. 2007ViewMedical Device & Equipment ManufacturingFundingViewCompletedDetails
Dec. 2007ViewBiopharmaceuticalsFundingViewCompletedDetails
Aug. 2007ViewBiotechnologyAcquisitionViewCompletedDetails
May. 2007ViewBiotherapeuticsFundingViewCompletedDetails
Feb. 2007ViewDrug Delivery TechnologyFundingViewCompletedDetails
Jan. 2007ViewMedical Device Design & ManufacturingFundingViewCompletedDetails
Oct. 2005Gynesonics, Inc.Medical Device Design & ManufacturingFunding$3,871,541CompletedDetails
Oct. 2005Portola Pharmaceuticals, Inc.BiotherapeuticsFunding$46,500,000CompletedDetails
Aug. 2005AdianaBiotechnologyFunding$23,000,000CompletedDetails
Jan. 2005LabcyteMedical Devices & EquipmentFunding$21,000,000CompletedDetails
Nov. 2003Portola Pharmaceuticals, Inc.BiotherapeuticsFunding$22,250,000CompletedDetails
Jul. 2002LabcyteMedical Devices & EquipmentFunding$22,000,000CompletedDetails

Supplemental Resources

For additional information on Abingworth Management Ltd., or on private company investing, you can see the following:
What's included with your PrivCo Premium Subscription:
Next Actions on Abingworth Management Ltd.:
View Deal ActivityView Direct E-mail Contacts
  • Learn More About PrivCo
  • PrivCo’s Clients Include:
  • Clients Include: Motorola, 3M, Samsung, Oracle, TATA, Johnson and Johnson, CB Richard Ellis
  • PrivCo Is Featured In:
  • Featured In: The New York Times, New York Post, Bloomberg, CNBC, NPR, The Washington Post, The Wall Street Journal, CNN, Fortune, BusinessWeek, Reuters, CBS News, USA Today
PrivCo’s 300-page Private Company Tech M&A Report for 2012 - Click Here For Full Report
  • Quick Investor Search

within miles
Go to Advanced Search
  • What is PrivCo?

PrivCo is the authority for financial & business data on major private market investors, including:

PrivCo Private Deals Newsletter.
It's FREE!

This is the PrivCo Investor Profile for Abingworth Management Ltd.
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor Abingworth Management Ltd.
To unlock all information in this profile: Upgrade to PrivCo Premium